Champions Oncology Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $16.559M Miss $16.613M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.09 by 55.56 percent. This is a 88.89 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $16.559 million which missed the analyst consensus estimate of $16.613 million by 0.33 percent. This is a 2.82 percent decrease over sales of $17.039 million the same period last year.